MAIDEN HOLDINGS LTD (MHLD) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:MHLD • BMG5753U1128

1.15 USD
+0.15 (+15%)
At close: May 27, 2025
1.15 USD
0 (0%)
After Hours: 5/27/2025, 8:00:00 PM
Fundamental Rating

0

MHLD gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 149 industry peers in the Insurance industry. MHLD may be in some trouble as it scores bad on both profitability and health. MHLD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year MHLD has reported negative net income.
  • MHLD had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: MHLD reported negative net income in multiple years.
  • MHLD had a negative operating cash flow in each of the past 5 years.
MHLD Yearly Net Income VS EBIT VS OCF VS FCFMHLD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

1.2 Ratios

  • MHLD has a worse Return On Assets (-17.10%) than 93.71% of its industry peers.
  • MHLD has a worse Return On Equity (-561.77%) than 95.10% of its industry peers.
Industry RankSector Rank
ROA -17.1%
ROE -561.77%
ROIC N/A
ROA(3y)-4.94%
ROA(5y)-1.43%
ROE(3y)-146.93%
ROE(5y)-79.11%
ROIC(3y)N/A
ROIC(5y)N/A
MHLD Yearly ROA, ROE, ROICMHLD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

  • MHLD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MHLD Yearly Profit, Operating, Gross MarginsMHLD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

0

2. Health

2.1 Basic Checks

  • MHLD has less shares outstanding than it did 1 year ago.
  • MHLD has more shares outstanding than it did 5 years ago.
  • MHLD has a worse debt/assets ratio than last year.
MHLD Yearly Shares OutstandingMHLD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
MHLD Yearly Total Debt VS Total AssetsMHLD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • MHLD has a Debt/Equity ratio of 6.78. This is a high value indicating a heavy dependency on external financing.
  • MHLD has a Debt to Equity ratio of 6.78. This is amonst the worse of the industry: MHLD underperforms 95.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.78
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
MHLD Yearly LT Debt VS Equity VS FCFMHLD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MHLD Yearly Current Assets VS Current LiabilitesMHLD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

0

3. Growth

3.1 Past

  • The earnings per share for MHLD have decreased strongly by -734.18% in the last year.
  • The Revenue for MHLD has decreased by -44.99% in the past year. This is quite bad
  • The Revenue for MHLD have been decreasing by -37.29% on average. This is quite bad
EPS 1Y (TTM)-734.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-700%
Revenue 1Y (TTM)-44.99%
Revenue growth 3Y-17.22%
Revenue growth 5Y-37.29%
Sales Q2Q%-47.47%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MHLD Yearly Revenue VS EstimatesMHLD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
MHLD Yearly EPS VS EstimatesMHLD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 0 20 -20 -40 -60 -80 -100

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MHLD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MHLD Price Earnings VS Forward Price EarningsMHLD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MHLD Per share dataMHLD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30 -40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • MHLD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MAIDEN HOLDINGS LTD

NASDAQ:MHLD (5/27/2025, 8:00:00 PM)

After market: 1.15 0 (0%)

1.15

+0.15 (+15%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-12
Earnings (Next)08-06
Inst Owners319.28%
Inst Owner Change0%
Ins Owners64.46%
Ins Owner Change0%
Market Cap114.63M
Revenue(TTM)46.56M
Net Income(TTM)-211.07M
Analysts43.33
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.46
P/FCF N/A
P/OCF N/A
P/B 3.05
P/tB 3.05
EV/EBITDA N/A
EPS(TTM)-42.46
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.97
FCFYN/A
OCF(TTM)-0.97
OCFYN/A
SpS0.47
BVpS0.38
TBVpS0.38
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -17.1%
ROE -561.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.94%
ROA(5y)-1.43%
ROE(3y)-146.93%
ROE(5y)-79.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 6.78
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-734.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-700%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-44.99%
Revenue growth 3Y-17.22%
Revenue growth 5Y-37.29%
Sales Q2Q%-47.47%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-549.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y31.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.08%
OCF growth 3YN/A
OCF growth 5YN/A

MAIDEN HOLDINGS LTD / MHLD FAQ

Can you provide the ChartMill fundamental rating for MAIDEN HOLDINGS LTD?

ChartMill assigns a fundamental rating of 0 / 10 to MHLD.


What is the valuation status of MAIDEN HOLDINGS LTD (MHLD) stock?

ChartMill assigns a valuation rating of 0 / 10 to MAIDEN HOLDINGS LTD (MHLD). This can be considered as Overvalued.


What is the profitability of MHLD stock?

MAIDEN HOLDINGS LTD (MHLD) has a profitability rating of 0 / 10.


Can you provide the financial health for MHLD stock?

The financial health rating of MAIDEN HOLDINGS LTD (MHLD) is 0 / 10.